A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC)
Trial Number
NCT03740165Contact Person
Status
Closed to Recruitment
Disease Site
Ovarian Newly Diagnosed
Lead Cooperative Group
Participating Groups
GOG-F
CEEGOG
GEICO
GINECO
ISGO
MaNGO
MITO
NOGGO
GOTIC
KGOG
PMHC